Biocon Limited, a biopharmaceutical company, manufactures pharmaceuticals, and medicinal chemical and botanical products. The company operates through Generics, Novel Biologics, Biosimilars, and Research Services segments. It focuses in the areas of diabetes, oncology, immunology, ophthalmology, and bone health diseases. In addition, It is involved in the integrated discovery, development, and manufacturing services for small and large molecules. The company serves customers in approximately 120 countries. Biocon Limited was founded in 1978 and is headquartered in Bengaluru, India.

Biocon Limited

Biocon is a biopharmaceutical company that provides access to affordable quality medicines. It is involved in developing and manufacturing a range of pharmaceuticals, including generics, biosimilars, and novel biologics.

Metric
Company Name	Biocon Limited
Symbol	BIOCON
MSH ID	COM:BIOCON
Market	STOCKS
Sector	Healthcare
Industry	Biotechnology
Country	IN
Stage
Employee Count	16.55K
Website	biocon.com
LinkedIn
Founders

Metric
Market Cap	5.03B
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	1.74B
Revenue (LTM)
Revenue (NTM)
Gross Profit	673.98M
EBITDA	389.45M
Operating Income	204.23M
Net Income	120.72M
EPS	0.10
Diluted EPS	0.10
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.66
Operating Profit Margin	0.19
EBITDA Margin	0.22
Net Profit Margin	0.11
Return on Equity	0.08
Return on Assets	0.03
Return on Capital Employed	0.06

COM:BIOCON

Biocon

Last Close

331.50

25/11 09:40

Market Cap

425.67B

Beta: -

Volume Today

1.24M

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	68.32
P/B Ratio	1.79
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	3.27
EV Multiple	8.38

Metric
Days Sales Outstanding	112.40
Days Payables Outstanding	352.75
Days Inventory Outstanding	382.18
Operating Cycle	502.36
Cash Conversion Cycle	111.03
Asset Turnover	0.26

Metric
Operating Cash Flow	265.77M
Free Cash Flow	37.72M
Cash Flow to Debt	0.16
Operating Cash Flow/Sales	0.17
Free Cash Flow Yield	0.00

Metric
Cash & Equivalents	266.66M
Accounts Receivable	-285.40M
Inventory	583.68M
Goodwill	1.93B
Debt to Capitalization	0.45
Debt to Assets	0.33
Current Ratio	1.36
Quick Ratio	0.67

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.01
R&D to Revenue	0.00
SG&A to Revenue